At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Jun 16, 2026 at 16:46 ET
Two directors of Travere Therapeutics (TVTX) exercised stock options and immediately sold the resulting shares on June 12, 2026, for a total of ~$726K in open-market sales. The combined sales represent only 0.015% of the company's $5.0B market cap, making this a routine, liquidity-driven transaction with no material informational content.
- Directors Timothy Coughlin and Roy D. Baynes each exercised stock options and sold shares on June 12, 2026.
- Coughlin sold 10,000 shares at $50.07 for $500,747; Baynes sold 4,500 shares at $50.00 for $225,000.
- Total open-market sales: $725,747, or ~0.015% of TVTX's $5.0B market cap.
- Both sales followed option exercises (cash and non-cash), indicating a typical exercise-and-sell pattern rather than a bearish signal.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access